Pharmaceutics funding

UK registered organisations, including businesses, academic institutions, RTOs, charities, nonprofits and public-sector organisations; single and collaborative applications accepted.

Postdoctoral researchers at accredited US doctoral-granting universities with a terminal research doctorate awarded on or after 1 January 2024 and at least two first-author publications. One applicant per lab per programme cycle. NIH K99/R00 or F recipients and first-cycle full-application invitees are ineligible; overlapping stipend support is prohibited.

Consortia must include at least one existing business and one research organisation. Businesses need a completed annual accounting period and at least 40% of the project budget. Research must take place in Attica and match the region’s RIS3 priorities.